Abstract

BackgroundSeveral firstline disease modifying therapies (DMTs) have shown significant benefit in preventing relapses and slowing disease progression among multiple sclerosis (MS) patients. Lower adherence may be associated with lower efficacy...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
Neetu Agashivala ... Edward Kim
BMC Neurology | VOL. 13
Neetu Agashivala, et. al.Neetu Agashivala ... Edward Kim
04 Oct 2013
Characteristics of COVID-19 disease in multiple sclerosis patients
Mahdi Barzegar ... Reza Vosoughi
Multiple sclerosis and related disorders | VOL. 45
Mahdi Barzegar, et. al.Mahdi Barzegar ... Reza Vosoughi
08 Jun 2020
Correlates and barriers to medication adherence in multiple sclerosis patients and their impact on clinical outcomes
Jenna Lee ... Martha Stutsky
Journal of Drug Assessment | VOL. 8
Jenna Lee, et. al.Jenna Lee ... Martha Stutsky
03 Sep 2019
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis
Nina Parikh Thomas ... Dana Hurley
Journal of Medical Economics | VOL. 19
Nina Parikh Thomas, et. al.Nina Parikh Thomas ... Dana Hurley
18 Jan 2016
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports
Lorene Lipszyc ... Samy Babai
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lorene Lipszyc, et. al.Lorene Lipszyc ... Samy Babai
22 Jul 2024
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions
Alena Pilková ... Martin Matoulek
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Alena Pilková, et. al.Alena Pilková ... Martin Matoulek
17 Jul 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management
Giulia Cancellieri ... Piera Polidori
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Giulia Cancellieri, et. al.Giulia Cancellieri ... Piera Polidori
15 Jul 2024
View more papers